Skip to main content

Table 1 Baseline characteristics of patients

From: Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial

 

Arm 1 n = 10

Arm 2 n = 10

Age (Mean ± SD) years

54 ± 11

50 ± 12

Sex (M/F)

8/2

9/1

Duration of HIV infection (Mean ± SD) in months

20 ± 17

15 ± 3

Duration of 1st line therapy (Mean ± SD) in months

14 ± 12

10 ± 3

Duration of undetectable viral load (Mean ± SD) in monhs

13 ± 19

6 ± 2

CD4+ cells/mm3 (Mean ± SD)

598 ± 380

744 ± 377

CD4+ cells/mm3nadir (Mean ± SD)

270 ± 120

290 ± 210

CD8+ cells/mm3 (Mean ± SD)

813 ± 414

927 ± 352

Viral load single copy assay Nb positive cases

1/10 (6 copies/ml)

1/10 (8 copies/ml)

HIV DNA copies/106PBMC (Mean ± SD)

41 ± 37

24 ± 22

HIV RNA copies/106PBMC (Mean ± SD)

43 ± 28

32 ± 23

CCR5 tropism Nb of patients

10/10

9/10

  1. For each parameter, the data are pooled results obtained at W-2 and at W0 is used. SD: standard deviation.